Based on recent data, CG Oncology Inc. (CGON) shows an Average True Range (ATR) of 2.87 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 1.02M, indicating liquidity. These fundamental metrics provide insight into CGON's underlying financial health and market activity.
| ATR | 2.87 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 1.02M |
| Avg Vol (10 Days) | 770.73K |
CG Oncology Inc. (CGON) technical indicators as of July 28, 2026: the SMA 20 is 4.14%, SMA 50 at 13.79%, and SMA 200 at 52.02%. The RSI 14 value is 58.08, suggesting its current momentum. These technical analysis signals help assess CGON's price trends and potential future movements.
| SMA 20 | 4.14% |
| SMA 50 | 13.79% |
| SMA 200 | 52.02% |
| RSI 14 | 58.08 |
CG Oncology Inc. (CGON) stock performance overview as of July 28, 2026: The 52-week high is $77 (currently -6.48% below), and the 52-week low is $23.65 (currently 279.12% above). Over the past year, CGON's performance is 87.94%, compared to the S&P 500's 3.36% change.
| 52-Week High | 77 |
| 52-Week High Chg | -6.48% |
| 52-Week Low | 23.65 |
| 52-Week Low Chg | +279.12% |
| S&P 500 52-Week Chg | 3.36% |
According to market data, CG Oncology Inc. (CGON) stock's recent performance metrics show that over the last month, CGON is 46.35%, with a Year-to-Date (YTD) performance of 31.72%. Over the past year, the stock has seen a 87.94% change. These figures summarize CGON's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 73.89 | 77 | 77 | 77 | 77 | 77 |
| Low | 68 | 67.43 | 53.21 | 48.51 | 23.65 | 39.14 |
| Performance | +1.81% | +46.35% | +31.91% | +103.31% | +87.94% | +31.72% |
According to current financial data, CGON stock's P/E (TTM) ratio is -30.64, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CGON, including P/S (1247.02), P/B (5.55), and P/FCF (-39.42), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CGON | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -30.64 | -1.24 | -194.78 | 32.59 |
| P/S (TTM) | 1247.02 | 3.7 | 468.69 | 5.98 |
| P/B (TTM) | 5.55 | 0 | -3496.43 | 5.59 |
| P/FCF (TTM) | -39.42 | -0.33 | -619.54 | 31.65 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep